4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0000899243-21-041580
10% owner bought 250,000 shares at $16.00 ($4,000,000)
- 10% owner acquired 1,191,444 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RiverVest Venture Fund IV, L.P. 10% owner | 2021-10-26 | Conversion | +832,120 | 832,120 | I: show line 1 in the form | ||
| RiverVest Venture Fund IV, L.P. 10% owner | 2021-10-26 | Conversion | +359,324 | 1,191,444 | I: show line 2 in the form | ||
| RiverVest Venture Fund IV, L.P. 10% owner | 2021-10-26 | Purchase | +250,000 | $16.00 | $4,000,000 | 1,441,444 | I: show line 3 in the form |
| Open-market purchases · 250,000 sh · avg $16.00 · $4,000,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| RiverVest Venture Fund IV, L.P. 10% owner | 2021-10-26 | Conversion · Series B Preferred Stock | −832,120 | 0 | I: show line 4 in the form | |||||
| RiverVest Venture Fund IV, L.P. 10% owner | 2021-10-26 | Conversion · Series B Preferred Stock | −359,324 | 0 | I: show line 5 in the form |
Loading xslF345X03/doc4.xml…